Back to search
FDAFDA · Food and drugs·Recall number D-0517-2024

Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubicon Research Private Limited, Ambernath Dist Thane 421506 India, NDC 52817-360-00

Published June 5, 2024 · Recall initiated: May 6, 2024

Summary

FDA records drug Class II recall D-0517-2024, published June 5, 2024 and initiated May 6, 2024. Recalling firm: Rubicon Research Private Limited; Status: Ongoing; Reported quantity: 11,664 Bottles; Lot: Lot 231037H1, exp 6/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: metal in tablet

What to do

Voluntary: Firm initiated

Get an email if METOPROLOL TARTRATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOPROLOL TARTRATE
Manufacturer
Rubicon Research Private Limited
Distributor
Nationwide
UPC
0352817361103
Lot
Lot 231037H1, exp 6/2027
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubicon Research Private Limited, Ambernath Dist Thane 421506 India, NDC 52817-360-00 recalled?

Yes. FDA published recall D-0517-2024 on June 5, 2024. Reported hazard: Presence of Foreign Substance: metal in tablet

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOPROLOL TARTRATE. UPC: 0352817361103.